Avanos Medical, Inc.AVNSNYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+360.0%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+360.0%/yr
vs -71.6%/yr prior
Acceleration
+431.5pp
Accelerating
Percentile
P97
Near historical high
vs 3Y Ago
97.3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 24.92% |
| Q3 2025 | -21.27% |
| Q2 2025 | 2.46% |
| Q1 2025 | -4.93% |
| Q4 2024 | 17.54% |
| Q3 2024 | -5.74% |
| Q2 2024 | -8.96% |
| Q1 2024 | 21.82% |
| Q4 2023 | 3.29% |
| Q3 2023 | -19.32% |
| Q2 2023 | 1.02% |
| Q1 2023 | 0.13% |
| Q4 2022 | 0.26% |
| Q3 2022 | -4.99% |
| Q2 2022 | -4.08% |
| Q1 2022 | 20.70% |
| Q4 2021 | -1.25% |
| Q3 2021 | 5.27% |
| Q2 2021 | -6.57% |
| Q1 2021 | 41.39% |
| Q4 2020 | -31.43% |
| Q3 2020 | 22.40% |
| Q2 2020 | -18.41% |
| Q1 2020 | -21.27% |
| Q4 2019 | 18.84% |
| Q3 2019 | 15.29% |
| Q2 2019 | -8.26% |
| Q1 2019 | 2.14% |
| Q4 2018 | -7.09% |
| Q3 2018 | 6.07% |
| Q2 2018 | -9.22% |
| Q1 2018 | 10.74% |
| Q4 2017 | -1.31% |
| Q3 2017 | -3.78% |
| Q2 2017 | -19.14% |
| Q1 2017 | -10.81% |
| Q4 2016 | 23.29% |
| Q3 2016 | -17.24% |
| Q2 2016 | 16.27% |
| Q1 2016 | -5.60% |